Histones and Heart Failure in Diabetes

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2018 Jun 24

PMID 29934664

Citations 13

Authors

Veera Ganesh Yerra

Andrew Advani

Affiliations

Soon will be listed here.

Abstract

Although heart failure is now accepted as being a major long-term complication of diabetes, many of the recent advances in our understanding of the pathobiology of diabetes complications have come about through the study of more traditional microvascular or macrovascular diseases. This has been the case, for example, in the evolving field of the epigenetics of diabetes complications and, in particular, the post-translational modification of histone proteins. However, histone modifications also occur in human heart failure and their perturbation also occurs in diabetic hearts. Here, we review the principal histone modifications and their enzymatic writers and erasers that have been studied to date; we discuss what is currently known about their roles in heart failure and in the diabetic heart; we draw on lessons learned from the studies of microvascular and macrovascular complications; and we speculate that therapeutically manipulating histone modifications may alter the natural history of heart failure in diabetes.

Citing Articles

Epigenetic mechanisms regulate sex differences in cardiac reparative functions of bone marrow progenitor cells.

Thej C, Roy R, Cheng Z, Garikipati V, Truongcao M, Joladarashi D NPJ Regen Med. 2024; 9(1):17.

PMID: 38684697 PMC: 11058271. DOI: 10.1038/s41536-024-00362-2.

Chronic kidney disease and left ventricular diastolic dysfunction (CKD-LVDD) alter cardiac expression of mitochondria-related genes in swine.

Chade A, Sitz R, Kelty T, McCarthy E, Tharp D, Rector R Transl Res. 2024; 267:67-78.

PMID: 38262578 PMC: 11001533. DOI: 10.1016/j.trsl.2023.12.004.

Machine learning-based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure.

de Bakker M, Petersen T, Rueten-Budde A, Akkerhuis K, Umans V, Brugts J Eur Heart J Digit Health. 2023; 4(6):444-454.

PMID: 38045440 PMC: 10689916. DOI: 10.1093/ehjdh/ztad056.

Development of necroptosis-related gene signature to predict the prognosis of colon adenocarcinoma.

Li M, Zhang T, Chen W Front Genet. 2022; 13:1051800.

PMID: 36353119 PMC: 9639779. DOI: 10.3389/fgene.2022.1051800.

Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets.

Mengstie M, Abebe E, Teklemariam A, Mulu A, Teshome A, Zewde E Front Endocrinol (Lausanne). 2022; 13:947294.

PMID: 36120460 PMC: 9478122. DOI: 10.3389/fendo.2022.947294.

References

Kalashnikova A, Rogge R, Hansen J . Linker histone H1 and protein-protein interactions. Biochim Biophys Acta. 2015; 1859(3):455-61. PMC: 4775371. DOI: 10.1016/j.bbagrm.2015.10.004. View

Richon V, Garcia-Vargas J, Hardwick J . Development of vorinostat: current applications and future perspectives for cancer therapy. Cancer Lett. 2009; 280(2):201-10. DOI: 10.1016/j.canlet.2009.01.002. View

Siddiqi F, Majumder S, Thai K, Abdalla M, Hu P, Advani S . The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes. J Am Soc Nephrol. 2015; 27(7):2021-34. PMC: 4926960. DOI: 10.1681/ASN.2014090898. View

Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

Zhang L, Du J, Yano N, Wang H, Zhao Y, Dubielecka P . Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice. J Cell Biochem. 2017; 118(8):2395-2408. PMC: 5462877. DOI: 10.1002/jcb.25902. View

Hyun K, Jeon J, Park K, Kim J . Writing, erasing and reading histone lysine methylations. Exp Mol Med. 2017; 49(4):e324. PMC: 6130214. DOI: 10.1038/emm.2017.11. View

Wolf S . The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans. Cell Mol Life Sci. 2009; 66(13):2109-21. PMC: 11115746. DOI: 10.1007/s00018-009-0010-x. View

Vecellio M, Spallotta F, Nanni S, Colussi C, Cencioni C, Derlet A . The histone acetylase activator pentadecylidenemalonate 1b rescues proliferation and differentiation in the human cardiac mesenchymal cells of type 2 diabetic patients. Diabetes. 2014; 63(6):2132-47. DOI: 10.2337/db13-0731. View

Nassif M, Kosiborod M . Effect of glucose-lowering therapies on heart failure. Nat Rev Cardiol. 2018; 15(5):282-291. DOI: 10.1038/nrcardio.2017.211. View

10.

Kaneda R, Takada S, Yamashita Y, Choi Y, Nonaka-Sarukawa M, Soda M . Genome-wide histone methylation profile for heart failure. Genes Cells. 2008; 14(1):69-77. DOI: 10.1111/j.1365-2443.2008.01252.x. View

11.

Tsilidis K, Kasimis J, Lopez D, Ntzani E, Ioannidis J . Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015; 350:g7607. DOI: 10.1136/bmj.g7607. View

12.

Kannel W, Hjortland M, CASTELLI W . Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974; 34(1):29-34. DOI: 10.1016/0002-9149(74)90089-7. View

13.

Cedar H, Bergman Y . Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009; 10(5):295-304. DOI: 10.1038/nrg2540. View

14.

Connelly K, Advani A, Advani S, Zhang Y, Kim Y, Shen V . Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies. Acta Diabetol. 2014; 51(5):771-82. DOI: 10.1007/s00592-014-0608-9. View

15.

Bulger M, Groudine M . Functional and mechanistic diversity of distal transcription enhancers. Cell. 2011; 144(3):327-39. PMC: 3742076. DOI: 10.1016/j.cell.2011.01.024. View

16.

Nathan D, Ingvarsdottir K, Sterner D, Bylebyl G, Dokmanovic M, Dorsey J . Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev. 2006; 20(8):966-76. PMC: 1472304. DOI: 10.1101/gad.1404206. View

17.

Sulaiman M, Matta M, Sunderesan N, Gupta M, Periasamy M, Gupta M . Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2009; 298(3):H833-43. PMC: 2838561. DOI: 10.1152/ajpheart.00418.2009. View

18.

Tsukada Y, Fang J, Erdjument-Bromage H, Warren M, Borchers C, Tempst P . Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2005; 439(7078):811-6. DOI: 10.1038/nature04433. View

19.

Masatsugu T, Yamamoto K . Multiple lysine methylation of PCAF by Set9 methyltransferase. Biochem Biophys Res Commun. 2009; 381(1):22-6. DOI: 10.1016/j.bbrc.2009.01.185. View

20.

Zhou S, Chen H, Wan Y, Zhang Q, Wei Y, Huang S . Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res. 2011; 109(6):639-48. DOI: 10.1161/CIRCRESAHA.111.243592. View